Catalogue number
PRO-801
Introduction
Mycoplasma pneumonia is part of the atypical pneumonia subtype which is caused by the bacteria M. pneumoniae. Mycoplasma pneumonia affects individuals younger than 40. It makes up 15 - 50% of all pneumonia cases in *****s and especially in school-aged children. People at great risk for mycoplasma pneumonia comprise of those living or working in busy areas such as schools and homeless shelters, although many people who contract mycoplasma pneumonia have no identifiable risk factor. P1, P30, and P116 of mycoplasma pneumonia membrane proteins have been recognized as adhensive factors, P1 is considered as a main adhension protein of the organism colonization.
Description
The Recombinant Mycoplasma Pneumoniae C-terminal region (P1C) of the P1 protein was expressed in E. coli containing 362 amino acids. The protein is fused to a 6 His Tag.
This peptide can be used as an antigen in the diagnosis of M. pneumoniae infection.
Source
E.Coli
Purification Method
The recombinant fusion protein was purified by GSH affinity chromatography technique.
Physical Appearance
Streile filtered colorless solution.
Formulation
Mycoplasma Pneumoniae P1-C is formulated in 1x PBS pH 7.4.
Stability
Upon arrival, Store at -20°C.
Please prevent freeze-thaw cycles.
Purity
Greater than 95% as determined by 12% PAGE (Coomassie staining).
Applications
Can be used for?lateral flow product, ELISA assay and vaccine development.
Safety Data Sheet
Usage
ProSpecs products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
